1. Home
  2. RBBN vs ORGO Comparison

RBBN vs ORGO Comparison

Compare RBBN & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$2.18

Market Cap

384.6M

Sector

Technology

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.24

Market Cap

348.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
ORGO
Founded
1997
1985
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
384.6M
348.6M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
RBBN
ORGO
Price
$2.18
$2.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$4.67
$8.50
AVG Volume (30 Days)
536.9K
545.0K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
170.97
1600.00
EPS
0.22
0.15
Revenue
N/A
$564,169,000.00
Revenue This Year
$1.97
N/A
Revenue Next Year
$6.69
$26.27
P/E Ratio
$9.91
$14.93
Revenue Growth
N/A
17.04
52 Week Low
$1.83
$2.21
52 Week High
$4.29
$7.08

Technical Indicators

Market Signals
Indicator
RBBN
ORGO
Relative Strength Index (RSI) 48.37 24.54
Support Level $2.07 N/A
Resistance Level $2.27 $2.51
Average True Range (ATR) 0.08 0.11
MACD 0.01 0.03
Stochastic Oscillator 60.87 5.98

Price Performance

Historical Comparison
RBBN
ORGO

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: